Dr. Silva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
80 Broadway Ste 2d
Cresskill, NJ 07626Phone+1 201-218-1380Fax+1 212-263-0202
Education & Training
- NYU Grossman School of MedicineFellowship, Child and Adolescent Psychiatry, 1990 - 1992
- Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital CenterFellowship, Child and Adolescent Psychiatry, 1988 - 1990
- Richmond University Medical CenterResidency, Psychiatry, 1984 - 1988
- Ross University School of MedicineClass of 1983
Certifications & Licensure
- NJ State Medical License 2007 - 2025
- NY State Medical License 1989 - 2017
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2012-2014
Publications & Presentations
PubMed
- 77 citationsFactors Related to Posttraumatic Stress Disorder in AdolescenceKate B. Nooner, L. Oriana Linares, Jessica Batinjane, Rachel Kramer, Raul R. Silva
Trauma, Violence & Abuse. 2012-06-04 - 23 citationsSide effects associated with lithium and placebo administration in aggressive children.Raul R. Silva, Magda Campbell, R R Golden, Arthur M. Small, C S Pataki
Psychopharmacology Bulletin. 1992-01-01 - 73 citationsA rating scale for disruptive behavior disorders, based on the DSM-IV item pool.Raul R. Silva, Murray Alpert, Enrique R. Pouget, Victoria Silva, Sarah Trosper
The Psychiatric Quarterly. 2005-01-01
Press Mentions
- Cingulate Announces Positive Fed/Fast Study Results of CTx-1301 ADHD Lead AssetFebruary 23rd, 2023
- Cingulate Completes Phase 3 Adult Trial of CTx-1301 (Dexmethylphenidate) for ADHDJune 9th, 2023
- Cingulate Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of ...September 12th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: